Application 021866

Type
NDA
Sponsor
OTSUKA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ABILIFYARIPIPRAZOLEINJECTABLE;INTRAMUSCULAR9.75MG/1.3ML (7.5MG/ML)NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
59148-016ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-016ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-016ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
61831SUPPL2020-02-06
61830SUPPL2020-02-06
61829SUPPL2020-02-06
61828SUPPL2020-02-06
61801SUPPL2020-02-06
61800SUPPL2020-02-06
59640SUPPL2019-08-08
59639SUPPL2019-08-08
59625SUPPL2019-08-08
47427SUPPL2017-03-02
47327SUPPL2017-02-24
45052SUPPL2016-08-23
45053SUPPL2016-08-18
37792SUPPL2016-01-22
6342SUPPL2016-01-20
16485SUPPL2014-12-15
6341SUPPL2014-12-15
6339SUPPL2014-07-11
37790SUPPL2014-06-10
37791SUPPL2013-08-09
6340SUPPL2013-08-05
28743SUPPL2012-02-27
37789SUPPL2012-02-24
42333SUPPL2012-01-27
42332SUPPL2012-01-27
21847SUPPL2012-01-27
44158ORIG2011-12-22
28742SUPPL2011-03-08
37788SUPPL2011-03-07
37786SUPPL2011-02-24
6337SUPPL2011-02-18
28741SUPPL2010-12-07
16484SUPPL2010-12-03
6338SUPPL2010-12-03
37787SUPPL2010-12-02
28740SUPPL2010-02-17
28733SUPPL2010-02-14
16481SUPPL2010-02-14
28739SUPPL2009-07-24
37785SUPPL2009-07-23
37784SUPPL2008-08-26
28738SUPPL2008-08-19
24222ORIG2008-08-12
21846ORIG2008-08-11
44655SUPPL2008-07-17
44654SUPPL2008-07-17
44653SUPPL2008-07-17
28736SUPPL2008-05-14
28735SUPPL2008-05-14
6335SUPPL2008-05-14
28737SUPPL2008-03-07
6336SUPPL2008-02-29
16483SUPPL2008-02-28
37783SUPPL2007-11-19
28734SUPPL2007-11-19
6334SUPPL2007-11-08
16482SUPPL2007-11-07
28732SUPPL2007-10-04
16480SUPPL2007-09-26
6333ORIG2006-09-25
37782ORIG2006-09-21
51608SUPPL1900-01-01